Thanks for your comments Billy.
Not disputing that they will have various paths available to get to market faster with fast track, orphan and potentially Breakthrough therapy. Agree on that with you. However I am convinced that this is a small molecule class drug and not a biologic drug.
It is produced by chemical synthesis. see this http://nzic.org.nz/CiNZ/articles/CiNZ Jul 2011_brimble.pdf
https://neurogram.wordpress.com/2014/11/11/neurens-phase-ii-success-in-rett-syndrome/
http://adisinsight.springer.com/drugs/21885
http://www.**ionline.net/Biosimilars/Research/Small-molecule-versus-biological-drugs
35-40 Cents base case. Here's why., page-6
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |